SUBSCRIBERS
Merck weighing acquisition of Cubist for more than US$7b: sources
Deal, if announced, would be another multibillion-dollar health care transaction in a banner year for M&A
Published Sun, Dec 7, 2014 · 09:50 PM
New York
DRUGMAKER Merck & Co is in talks to acquire the biopharmaceuticals company Cubist for more than US$7 billion, according to people briefed on the matter.
The deal, if announced, would represent another multibillion-dollar health care transaction in a banner year for mergers and acquisitions in the industry.
Share with us your feedback on BT's products and services
